[
  {
    "ts": null,
    "headline": "Justice Department Sues Big Medicare Insurers Alleging Kickbacks",
    "summary": "The complaint alleged that CVS Health-unit Aetna, Elevance Health and Humana paid the kickbacks to brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.",
    "url": "https://finnhub.io/api/news?id=e5ea61259ab34bf2197edc50961f277730a6736b911f445f0f0aa550b7f86f9a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746141240,
      "headline": "Justice Department Sues Big Medicare Insurers Alleging Kickbacks",
      "id": 134185011,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The complaint alleged that CVS Health-unit Aetna, Elevance Health and Humana paid the kickbacks to brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.",
      "url": "https://finnhub.io/api/news?id=e5ea61259ab34bf2197edc50961f277730a6736b911f445f0f0aa550b7f86f9a"
    }
  },
  {
    "ts": null,
    "headline": "US Claims Medicare Insurers, Brokers Used Illegal Kickbacks",
    "summary": "(Bloomberg) -- The US sued top health insurance companies and brokers, alleging they used illegal kickbacks to steer members into certain private Medicare Advantage plans.Most Read from BloombergNJ Transit Urges Commuters to Work Remotely If Union StrikesNYC Lost $9 Billion of Income to Miami, Palm Beach in Five YearsNew York City Transit System Chips Away at Subway Fare EvasionNYC’s Congestion Toll Raised $159 Million in the First QuarterNYC’s MTA to Cut Costs Instead of Borrowing More to Fund",
    "url": "https://finnhub.io/api/news?id=04b5fc239ac66120d4217f96626bfeb6574fdb9f2374332539bbbf260ca81d4f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746136507,
      "headline": "US Claims Medicare Insurers, Brokers Used Illegal Kickbacks",
      "id": 134185012,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- The US sued top health insurance companies and brokers, alleging they used illegal kickbacks to steer members into certain private Medicare Advantage plans.Most Read from BloombergNJ Transit Urges Commuters to Work Remotely If Union StrikesNYC Lost $9 Billion of Income to Miami, Palm Beach in Five YearsNew York City Transit System Chips Away at Subway Fare EvasionNYC’s Congestion Toll Raised $159 Million in the First QuarterNYC’s MTA to Cut Costs Instead of Borrowing More to Fund",
      "url": "https://finnhub.io/api/news?id=04b5fc239ac66120d4217f96626bfeb6574fdb9f2374332539bbbf260ca81d4f"
    }
  },
  {
    "ts": null,
    "headline": "CVS stock reacts to full-year guidance, Novo Nordisk GLP-1 deal",
    "summary": "CVS Health (CVS) is maintaining Thursday gains ahead of the closing bell after outpacing top and bottom line expectations, paired with a positive full-year outlook for 2025. Yahoo Finance senior health reporter Anjalee Khemlani joins the Market Domination in breaking down the pharmacy chain's reaction to Medicare Advantage costs and its formulary deal with GLP-1 weight-loss drug developer Novo Nordisk (NVO). She highlights comments from CVS CEO David Joyner on the Novo Nordisk deal. Jefferies equity research analyst Brian Tanquilut explained to Yahoo Finance why it is looking like a \"new day\" for CVS on these earnings and guidance prints. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=76c0e059f4bf211f653a8a229019f71b69eb870a783cc1a4febda06b50c857d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746129402,
      "headline": "CVS stock reacts to full-year guidance, Novo Nordisk GLP-1 deal",
      "id": 134185057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) is maintaining Thursday gains ahead of the closing bell after outpacing top and bottom line expectations, paired with a positive full-year outlook for 2025. Yahoo Finance senior health reporter Anjalee Khemlani joins the Market Domination in breaking down the pharmacy chain's reaction to Medicare Advantage costs and its formulary deal with GLP-1 weight-loss drug developer Novo Nordisk (NVO). She highlights comments from CVS CEO David Joyner on the Novo Nordisk deal. Jefferies equity research analyst Brian Tanquilut explained to Yahoo Finance why it is looking like a \"new day\" for CVS on these earnings and guidance prints. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=76c0e059f4bf211f653a8a229019f71b69eb870a783cc1a4febda06b50c857d8"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'",
    "summary": "Eli Lilly's CEO waved off the Novo Nordisk-CVS GLP-1 formulary deal as he focuses on the future of the company's obesity pipeline.",
    "url": "https://finnhub.io/api/news?id=8181f963111e12c230e1e6281c49934ec8eafb69a57166845b72dc357eb8ab98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746124942,
      "headline": "Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'",
      "id": 134184707,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Eli Lilly's CEO waved off the Novo Nordisk-CVS GLP-1 formulary deal as he focuses on the future of the company's obesity pipeline.",
      "url": "https://finnhub.io/api/news?id=8181f963111e12c230e1e6281c49934ec8eafb69a57166845b72dc357eb8ab98"
    }
  },
  {
    "ts": null,
    "headline": "3 things we've learned from healthcare earnings",
    "summary": "Yahoo Finance Senior Health Reporter Anjalee Khemlani joins the Wealth team in breaking down the biggest themes she is seeing in the healthcare space from this earnings season, ranging from CVS Health's (CVS) earnings beat, trends in health insurance providers, rising medical costs, and the pricing on GLP-1 weight-loss drugs. Catch Anjalee's coverage of Eli Lilly's (LLY) stock reaction to its earnings print. Also, watch Yahoo Finance's interview with Oscar Health (OSCR) CEO Mark Bertolini from December 2024, where he characterized the healthcare system as having been \"broken for some time.\" To watch more expert insights and analysis on the latest market action, check out more Wealth here.",
    "url": "https://finnhub.io/api/news?id=8127865b5be6a61a9a94ea3e6034bccf792724ba2932afcf6cccdd30303fcfcf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746122641,
      "headline": "3 things we've learned from healthcare earnings",
      "id": 134184708,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Yahoo Finance Senior Health Reporter Anjalee Khemlani joins the Wealth team in breaking down the biggest themes she is seeing in the healthcare space from this earnings season, ranging from CVS Health's (CVS) earnings beat, trends in health insurance providers, rising medical costs, and the pricing on GLP-1 weight-loss drugs. Catch Anjalee's coverage of Eli Lilly's (LLY) stock reaction to its earnings print. Also, watch Yahoo Finance's interview with Oscar Health (OSCR) CEO Mark Bertolini from December 2024, where he characterized the healthcare system as having been \"broken for some time.\" To watch more expert insights and analysis on the latest market action, check out more Wealth here.",
      "url": "https://finnhub.io/api/news?id=8127865b5be6a61a9a94ea3e6034bccf792724ba2932afcf6cccdd30303fcfcf"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Climbs After CVS Earnings - Health Care Roundup",
    "summary": "Health-care companies rose after strong earnings from one drug-store chain. CVS Health soared after it logged quarterly earnings ahead of Wall Street targets. The Department of Justice filed a...",
    "url": "https://finnhub.io/api/news?id=71c0fad74265c255f22a2075d9f9c531b89880efee66d708b45697b69bf697f8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746121878,
      "headline": "Health Care Climbs After CVS Earnings - Health Care Roundup",
      "id": 134177916,
      "image": "",
      "related": "CVS",
      "source": "Finnhub",
      "summary": "Health-care companies rose after strong earnings from one drug-store chain. CVS Health soared after it logged quarterly earnings ahead of Wall Street targets. The Department of Justice filed a...",
      "url": "https://finnhub.io/api/news?id=71c0fad74265c255f22a2075d9f9c531b89880efee66d708b45697b69bf697f8"
    }
  },
  {
    "ts": null,
    "headline": "Lilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s Wegovy",
    "summary": "Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.",
    "url": "https://finnhub.io/api/news?id=0142d10cfe7cd5695c6d466ca1328e5f60a9985a7e3cc19803ce29752ff615ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746121487,
      "headline": "Lilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s Wegovy",
      "id": 134175948,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.",
      "url": "https://finnhub.io/api/news?id=0142d10cfe7cd5695c6d466ca1328e5f60a9985a7e3cc19803ce29752ff615ab"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health (NYSE:CVS) Reports Revenue Growth But Lowers Full-Year Earnings Guidance",
    "summary": "CVS Health (NYSE:CVS) reported robust year-over-year growth in Q1 2025 earnings, with significant increases in sales, revenue, and net income, though the company adjusted its annual earnings guidance downward. This financial performance, coupled with market trends where major indices including the S&P 500 and Dow continued their upward trajectory, likely contributed to the company's 17% share price increase over the last quarter. While broader market gains were supported by strong tech...",
    "url": "https://finnhub.io/api/news?id=2b8303ce0bd499f6475d95628e6d07d3caccb46d549b2ab025b794feb579ef27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746121459,
      "headline": "CVS Health (NYSE:CVS) Reports Revenue Growth But Lowers Full-Year Earnings Guidance",
      "id": 134185061,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (NYSE:CVS) reported robust year-over-year growth in Q1 2025 earnings, with significant increases in sales, revenue, and net income, though the company adjusted its annual earnings guidance downward. This financial performance, coupled with market trends where major indices including the S&P 500 and Dow continued their upward trajectory, likely contributed to the company's 17% share price increase over the last quarter. While broader market gains were supported by strong tech...",
      "url": "https://finnhub.io/api/news?id=2b8303ce0bd499f6475d95628e6d07d3caccb46d549b2ab025b794feb579ef27"
    }
  },
  {
    "ts": null,
    "headline": "Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health",
    "summary": "Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.  CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1.  The formulary is maintained by CVS Health’s pharmacy benefits management business, which runs prescription drug coverage for millions of people.",
    "url": "https://finnhub.io/api/news?id=3a227ed953be34701ae75ad7fc94f66de4cf247f3fdc60c2924012f112c2e62f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746118947,
      "headline": "Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health",
      "id": 134184711,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.  CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1.  The formulary is maintained by CVS Health’s pharmacy benefits management business, which runs prescription drug coverage for millions of people.",
      "url": "https://finnhub.io/api/news?id=3a227ed953be34701ae75ad7fc94f66de4cf247f3fdc60c2924012f112c2e62f"
    }
  },
  {
    "ts": null,
    "headline": "DOJ accuses CVS, Humana, Elevance of paying kickbacks to Medicare Advantage brokers",
    "summary": "According to the Justice Department’s complaint, the insurers paid brokers eHealth, GoHealth and SelectQuote hundreds of millions of dollars for enrolling seniors in their MA coverage — regardless of the plans’ suitability for those members’ needs.",
    "url": "https://finnhub.io/api/news?id=b6e8b035cf2b6abec4b7ea0ee5cb633c0b07549743391ae036de9ebe129c9074",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746117600,
      "headline": "DOJ accuses CVS, Humana, Elevance of paying kickbacks to Medicare Advantage brokers",
      "id": 134185063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "According to the Justice Department’s complaint, the insurers paid brokers eHealth, GoHealth and SelectQuote hundreds of millions of dollars for enrolling seniors in their MA coverage — regardless of the plans’ suitability for those members’ needs.",
      "url": "https://finnhub.io/api/news?id=b6e8b035cf2b6abec4b7ea0ee5cb633c0b07549743391ae036de9ebe129c9074"
    }
  },
  {
    "ts": null,
    "headline": "CVS Stock Surges on Blowout Earnings, Guidance Hike",
    "summary": "Earnings came in at $2.25 a share on revenue of $94.6 billion in the quarter, way above analysts' expectations.",
    "url": "https://finnhub.io/api/news?id=b3b4027ebe635bf4fd94c4aab4fba88d7051e60bf9e63261b62e62644a2b32fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746117000,
      "headline": "CVS Stock Surges on Blowout Earnings, Guidance Hike",
      "id": 134173726,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Earnings came in at $2.25 a share on revenue of $94.6 billion in the quarter, way above analysts' expectations.",
      "url": "https://finnhub.io/api/news?id=b3b4027ebe635bf4fd94c4aab4fba88d7051e60bf9e63261b62e62644a2b32fc"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Microsoft, Eli Lilly, Kohl’s, Apple, Tesla, Meta, Qualcomm, CVS, and More",
    "summary": "These Stocks Moved the Most Today: Microsoft, Eli Lilly, Kohl’s, Apple, Tesla, Meta, Qualcomm, CVS, and More",
    "url": "https://finnhub.io/api/news?id=b3b3fab89dda9ed8cac4814a44ae01eb87c6da138792b4d9a33303cdcf2903c3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746116640,
      "headline": "These Stocks Moved the Most Today: Microsoft, Eli Lilly, Kohl’s, Apple, Tesla, Meta, Qualcomm, CVS, and More",
      "id": 134179060,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "These Stocks Moved the Most Today: Microsoft, Eli Lilly, Kohl’s, Apple, Tesla, Meta, Qualcomm, CVS, and More",
      "url": "https://finnhub.io/api/news?id=b3b3fab89dda9ed8cac4814a44ae01eb87c6da138792b4d9a33303cdcf2903c3"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly slides, CVS earnings, Qualcomm's soft guidance",
    "summary": "Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Eli Lilly's (LLY) declining share price despite topping first quarter earnings estimates, CVS Health's (CVS) recent earnings beat, and chipmaker Qualcomm (QCOM) issuing soft guidance over concerns around tariff pressures on smartphone demand. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=a12328428201f1242c9ae70dc4ec34b21d75beb8fecca5185b1b5838a72a3544",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746116375,
      "headline": "Eli Lilly slides, CVS earnings, Qualcomm's soft guidance",
      "id": 134173461,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Eli Lilly's (LLY) declining share price despite topping first quarter earnings estimates, CVS Health's (CVS) recent earnings beat, and chipmaker Qualcomm (QCOM) issuing soft guidance over concerns around tariff pressures on smartphone demand. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=a12328428201f1242c9ae70dc4ec34b21d75beb8fecca5185b1b5838a72a3544"
    }
  },
  {
    "ts": null,
    "headline": "Shares Fall for Some Insurance Companies, Brokers Named in DOJ Complaint",
    "summary": "Shares Fall for Some Insurance Companies, Brokers Named in DOJ Complaint",
    "url": "https://finnhub.io/api/news?id=4ae3b7c0112f1ff9734e7182521278fbd835ea97c5deaf9f06392ef6fe549d3f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746115080,
      "headline": "Shares Fall for Some Insurance Companies, Brokers Named in DOJ Complaint",
      "id": 134191977,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "Shares Fall for Some Insurance Companies, Brokers Named in DOJ Complaint",
      "url": "https://finnhub.io/api/news?id=4ae3b7c0112f1ff9734e7182521278fbd835ea97c5deaf9f06392ef6fe549d3f"
    }
  },
  {
    "ts": null,
    "headline": "US accuses health insurers, brokers of Medicare Advantage kickback scheme",
    "summary": "The U.S. Department of Justiceaccused three of the nation's largest health insurers of payinghundreds of millions of dollars in kickbacks to brokers inexchange for steering patients into the...",
    "url": "https://finnhub.io/api/news?id=0d3b6bf4835c35c8328496027104a06108b4f6480f2cc47b7bfa9dd5e94f4e9e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746112728,
      "headline": "US accuses health insurers, brokers of Medicare Advantage kickback scheme",
      "id": 134176523,
      "image": "",
      "related": "CVS",
      "source": "Finnhub",
      "summary": "The U.S. Department of Justiceaccused three of the nation's largest health insurers of payinghundreds of millions of dollars in kickbacks to brokers inexchange for steering patients into the...",
      "url": "https://finnhub.io/api/news?id=0d3b6bf4835c35c8328496027104a06108b4f6480f2cc47b7bfa9dd5e94f4e9e"
    }
  },
  {
    "ts": null,
    "headline": "CVS strikes a deal to offer Wegovy at a discount",
    "summary": "But you'll have to pay cash.",
    "url": "https://finnhub.io/api/news?id=7e48d0fc24f23c9072098b58e6bbaa03096ed7d92fa4da8a155c530a95d4b66c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746112624,
      "headline": "CVS strikes a deal to offer Wegovy at a discount",
      "id": 134175951,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "But you'll have to pay cash.",
      "url": "https://finnhub.io/api/news?id=7e48d0fc24f23c9072098b58e6bbaa03096ed7d92fa4da8a155c530a95d4b66c"
    }
  },
  {
    "ts": null,
    "headline": "Initial Claims More Than Expectations",
    "summary": "Initial Claims More Than Expectations.",
    "url": "https://finnhub.io/api/news?id=d27bd043aba3536e21b4c183991db375f28dd67bc9b950b9715e8c70298e15dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746112140,
      "headline": "Initial Claims More Than Expectations",
      "id": 134173728,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Initial Claims More Than Expectations.",
      "url": "https://finnhub.io/api/news?id=d27bd043aba3536e21b4c183991db375f28dd67bc9b950b9715e8c70298e15dd"
    }
  },
  {
    "ts": null,
    "headline": "CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business",
    "summary": "The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.",
    "url": "https://finnhub.io/api/news?id=0f456c9c43580d009276820201c08d9b194ceee88e6daa6f40b6d3a1314b4a07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746110460,
      "headline": "CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business",
      "id": 134173729,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.",
      "url": "https://finnhub.io/api/news?id=0f456c9c43580d009276820201c08d9b194ceee88e6daa6f40b6d3a1314b4a07"
    }
  },
  {
    "ts": null,
    "headline": "It's a 'new day' for CVS as strong Q1 beat brightens outlook",
    "summary": "CVS (CVS) stock jumped after beating first quarter earnings and revenue expectations. Jefferies Healthcare Services equity research analyst Brian Tanquilut explains how CVS's margin recovery and business diversification signal growing investor confidence. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=51f2ba79e65a913a80b2a6cf95b6ba41fc74964074982a01103b85274b478962",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746109678,
      "headline": "It's a 'new day' for CVS as strong Q1 beat brightens outlook",
      "id": 134173730,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS (CVS) stock jumped after beating first quarter earnings and revenue expectations. Jefferies Healthcare Services equity research analyst Brian Tanquilut explains how CVS's margin recovery and business diversification signal growing investor confidence. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=51f2ba79e65a913a80b2a6cf95b6ba41fc74964074982a01103b85274b478962"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Raises Full-Year Profit Outlook Following First-Quarter Beat",
    "summary": "CVS Health (CVS) on Thursday raised its full-year earnings outlook as the healthcare company reporte",
    "url": "https://finnhub.io/api/news?id=52c123e376700ee9c268d6f9865433b044120a24277dcd2dd9ffd779d62e17af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746108670,
      "headline": "CVS Health Raises Full-Year Profit Outlook Following First-Quarter Beat",
      "id": 134173731,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) on Thursday raised its full-year earnings outlook as the healthcare company reporte",
      "url": "https://finnhub.io/api/news?id=52c123e376700ee9c268d6f9865433b044120a24277dcd2dd9ffd779d62e17af"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly's Q1 win outweighed by Novo's CVS deal",
    "summary": "Eli Lilly (LLY) shares slid at the open despite topping first quarter estimates, with investors reacting to the company lowering its full-year profit outlook. Investors are also reacting to a new deal between rival Novo Nordisk (NVO) and CVS (CVS) that could sideline Lilly's weight-loss drug Zepbound. Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to break down what's weighing on Eli Lilly's stock. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Editor's note: The headline was updated to better reflect what is moving the stock.",
    "url": "https://finnhub.io/api/news?id=2ea9a089c01e2e9a3173bba13cf38f8589367c57958268c8930950b16345a874",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746108594,
      "headline": "Eli Lilly's Q1 win outweighed by Novo's CVS deal",
      "id": 134173467,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Eli Lilly (LLY) shares slid at the open despite topping first quarter estimates, with investors reacting to the company lowering its full-year profit outlook. Investors are also reacting to a new deal between rival Novo Nordisk (NVO) and CVS (CVS) that could sideline Lilly's weight-loss drug Zepbound. Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to break down what's weighing on Eli Lilly's stock. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Editor's note: The headline was updated to better reflect what is moving the stock.",
      "url": "https://finnhub.io/api/news?id=2ea9a089c01e2e9a3173bba13cf38f8589367c57958268c8930950b16345a874"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone",
    "summary": "Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click for why LLY growth remains strong.",
    "url": "https://finnhub.io/api/news?id=9a9f39f149eeba6f72e5aa8c7e4071119610becf1bc46b35da5f2499334b6d0c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746107792,
      "headline": "CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone",
      "id": 134176013,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click for why LLY growth remains strong.",
      "url": "https://finnhub.io/api/news?id=9a9f39f149eeba6f72e5aa8c7e4071119610becf1bc46b35da5f2499334b6d0c"
    }
  },
  {
    "ts": null,
    "headline": "CVS Stock Surges On Huge Q1 Beat Amid GLP-1 Deal With Novo Nordisk",
    "summary": "CVS Health blew past first-quarter earnings estimates early Thursday, while raising its full-year outlook by a smaller amount.  The pharmacy and health benefits giant also announced an agreement to make Novo Nordisk's Wegovy its preferred GLP-1 obesity medication.  CVS stock is sharply higher, while NVO also jumped in early stock market action.",
    "url": "https://finnhub.io/api/news?id=4b7e2170019c82b873ae3cdff8dcd285a50fef7099272b7dc6dc6a9b1fb0af22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746106910,
      "headline": "CVS Stock Surges On Huge Q1 Beat Amid GLP-1 Deal With Novo Nordisk",
      "id": 134173733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health blew past first-quarter earnings estimates early Thursday, while raising its full-year outlook by a smaller amount.  The pharmacy and health benefits giant also announced an agreement to make Novo Nordisk's Wegovy its preferred GLP-1 obesity medication.  CVS stock is sharply higher, while NVO also jumped in early stock market action.",
      "url": "https://finnhub.io/api/news?id=4b7e2170019c82b873ae3cdff8dcd285a50fef7099272b7dc6dc6a9b1fb0af22"
    }
  },
  {
    "ts": null,
    "headline": "Compared to Estimates, CVS Health (CVS) Q1 Earnings: A Look at Key Metrics",
    "summary": "While the top- and bottom-line numbers for CVS Health (CVS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=f4fe4dfed089c4ce97dc20d8445c9e153f39c5bcb55ec9f397747794d4f2d846",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746106233,
      "headline": "Compared to Estimates, CVS Health (CVS) Q1 Earnings: A Look at Key Metrics",
      "id": 134173734,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for CVS Health (CVS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=f4fe4dfed089c4ce97dc20d8445c9e153f39c5bcb55ec9f397747794d4f2d846"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Stock Surges as Q1 Results Handily Top Estimates",
    "summary": "CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped estimates.",
    "url": "https://finnhub.io/api/news?id=4bd474be9eb19bf8fc8315d129de2c9a281d30079b30676fb08c54156550f2f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746105994,
      "headline": "CVS Health Stock Surges as Q1 Results Handily Top Estimates",
      "id": 134173735,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped estimates.",
      "url": "https://finnhub.io/api/news?id=4bd474be9eb19bf8fc8315d129de2c9a281d30079b30676fb08c54156550f2f0"
    }
  },
  {
    "ts": null,
    "headline": "CVS Q1 Earnings & Revenues Beat, '25 EPS View Raised, Stock Up",
    "summary": "CVS Health delivers earnings and revenue beat in the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=3d8e8d71f7518ab394c631bf44dab0c98777feee2b2d47c245c814481eb5b27b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746105300,
      "headline": "CVS Q1 Earnings & Revenues Beat, '25 EPS View Raised, Stock Up",
      "id": 134173627,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health delivers earnings and revenue beat in the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=3d8e8d71f7518ab394c631bf44dab0c98777feee2b2d47c245c814481eb5b27b"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health rides improving Medicare business to better-than-expected first quarter",
    "summary": "CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better-than-expected first quarter.  The health care giant said Thursday that it also got a boost from better star ratings for its Medicare Advantage plans, which are privately run versions of the federal government coverage program.  CVS Health and other health insurance providers have been struggling for several quarters now with rising costs from their Medicare Advantage customers.",
    "url": "https://finnhub.io/api/news?id=c286ca9328a1fbaf6cea3e6ed5e3a89029d481e7d42d80d63e2c4c117c896e9b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746104034,
      "headline": "CVS Health rides improving Medicare business to better-than-expected first quarter",
      "id": 134173737,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better-than-expected first quarter.  The health care giant said Thursday that it also got a boost from better star ratings for its Medicare Advantage plans, which are privately run versions of the federal government coverage program.  CVS Health and other health insurance providers have been struggling for several quarters now with rising costs from their Medicare Advantage customers.",
      "url": "https://finnhub.io/api/news?id=c286ca9328a1fbaf6cea3e6ed5e3a89029d481e7d42d80d63e2c4c117c896e9b"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Value Fund Q1 2025 Commentary",
    "summary": "The challenge of constant and intense debates in the pursuit of better judgment and the surfacing of hidden truth within an always foggy market landscape is worth it.",
    "url": "https://finnhub.io/api/news?id=815603c58a6c60981789c59d688117925b6bf46711f610c0d1b153b4d8eb742b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746099900,
      "headline": "ClearBridge Value Fund Q1 2025 Commentary",
      "id": 134172846,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1990349798/image_1990349798.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The challenge of constant and intense debates in the pursuit of better judgment and the surfacing of hidden truth within an always foggy market landscape is worth it.",
      "url": "https://finnhub.io/api/news?id=815603c58a6c60981789c59d688117925b6bf46711f610c0d1b153b4d8eb742b"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health’s (NYSE:CVS) Q1: Beats On Revenue, Stock Soars",
    "summary": "Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7% year on year to $94.59 billion. Its non-GAAP profit of $2.25 per share was 34.6% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=319e090e535a330aef8fbbee94f1d415bb0b1912b9460e30be72ffa7e0a62673",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746099664,
      "headline": "CVS Health’s (NYSE:CVS) Q1: Beats On Revenue, Stock Soars",
      "id": 134173738,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7% year on year to $94.59 billion. Its non-GAAP profit of $2.25 per share was 34.6% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=319e090e535a330aef8fbbee94f1d415bb0b1912b9460e30be72ffa7e0a62673"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health (CVS) Q1 Earnings and Revenues Beat Estimates",
    "summary": "CVS Health (CVS) delivered earnings and revenue surprises of 31.58% and 1.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=06004a0a66b6d65891279d6b7a2bb4eba4be55200af807033b6175ff206e5f55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746099605,
      "headline": "CVS Health (CVS) Q1 Earnings and Revenues Beat Estimates",
      "id": 134173739,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) delivered earnings and revenue surprises of 31.58% and 1.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=06004a0a66b6d65891279d6b7a2bb4eba4be55200af807033b6175ff206e5f55"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health: Why I'm Not Buying The Post-Earnings Share Buoyancy",
    "summary": "CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my analysis on CVS stock's earnings here.",
    "url": "https://finnhub.io/api/news?id=1a0d9a8df4f1fbf5af3dfb301065d05c577aa0dafbba67de4460f6ee27529147",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746099010,
      "headline": "CVS Health: Why I'm Not Buying The Post-Earnings Share Buoyancy",
      "id": 134172715,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2178256782/image_2178256782.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my analysis on CVS stock's earnings here.",
      "url": "https://finnhub.io/api/news?id=1a0d9a8df4f1fbf5af3dfb301065d05c577aa0dafbba67de4460f6ee27529147"
    }
  },
  {
    "ts": null,
    "headline": "U.S. stocks extend gains heading into midday",
    "summary": "U.S. stocks extend gains heading into midday",
    "url": "https://finnhub.io/api/news?id=a5cb4c4a2199991aacee0fd37247b35b7482bf717ef1b6796418736cf7a33021",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746098218,
      "headline": "U.S. stocks extend gains heading into midday",
      "id": 134179095,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "U.S. stocks extend gains heading into midday",
      "url": "https://finnhub.io/api/news?id=a5cb4c4a2199991aacee0fd37247b35b7482bf717ef1b6796418736cf7a33021"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health (CVS) Q1 2025 Earnings Call Transcript",
    "summary": "CVS Health (CVS) Q1 2025 Earnings Call Transcript",
    "url": "https://finnhub.io/api/news?id=d9e26f08175312c1a32a5c04cbfe2cb1dd6f6cb5129f03326fc5cb20fde509e2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746098197,
      "headline": "CVS Health (CVS) Q1 2025 Earnings Call Transcript",
      "id": 134172728,
      "image": "",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=d9e26f08175312c1a32a5c04cbfe2cb1dd6f6cb5129f03326fc5cb20fde509e2"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health: Q1 Earnings Snapshot",
    "summary": "WOONSOCKET, R.I. (AP) — CVS Health Corporation (CVS) on Thursday reported first-quarter net income of $1.78 billion. On a per-share basis, the Woonsocket, Rhode Island-based company said it had net income of $1.41. Earnings, adjusted for one-time gains and costs, came to $2.25 per share.",
    "url": "https://finnhub.io/api/news?id=270f86d83a1bff90de8a1a285b9de382688883e666b384e6375cac723a420b12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746095799,
      "headline": "CVS Health: Q1 Earnings Snapshot",
      "id": 134173740,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "WOONSOCKET, R.I. (AP) — CVS Health Corporation (CVS) on Thursday reported first-quarter net income of $1.78 billion. On a per-share basis, the Woonsocket, Rhode Island-based company said it had net income of $1.41. Earnings, adjusted for one-time gains and costs, came to $2.25 per share.",
      "url": "https://finnhub.io/api/news?id=270f86d83a1bff90de8a1a285b9de382688883e666b384e6375cac723a420b12"
    }
  },
  {
    "ts": null,
    "headline": "CVS raises profit forecast, to exit Obamacare market as turnaround gains steam",
    "summary": "(Reuters) -CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health insurance plans in 2026, as it seeks to turn around its fortunes after a series of challenges last year.  CVS shares jumped 5% to $69.84 after it raised its 2025 profit forecast to $6 to $6.20 per share from $5.75 to $6 previously.  CEO David Joyner, who took the helm of the healthcare conglomerate in October, has laid out cost-cutting plans and reshuffled the top management to help the company navigate one of the most challenging periods in its six-decade history.",
    "url": "https://finnhub.io/api/news?id=24cc40aceee16461105c000242e6510c9fed249a5bdf2779b8ab89551e2dd87a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746095728,
      "headline": "CVS raises profit forecast, to exit Obamacare market as turnaround gains steam",
      "id": 134173741,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "(Reuters) -CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health insurance plans in 2026, as it seeks to turn around its fortunes after a series of challenges last year.  CVS shares jumped 5% to $69.84 after it raised its 2025 profit forecast to $6 to $6.20 per share from $5.75 to $6 previously.  CEO David Joyner, who took the helm of the healthcare conglomerate in October, has laid out cost-cutting plans and reshuffled the top management to help the company navigate one of the most challenging periods in its six-decade history.",
      "url": "https://finnhub.io/api/news?id=24cc40aceee16461105c000242e6510c9fed249a5bdf2779b8ab89551e2dd87a"
    }
  },
  {
    "ts": null,
    "headline": "CVS posts Q1 earnings beat, raises full-year guidance",
    "summary": "CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare Advantage headwinds.",
    "url": "https://finnhub.io/api/news?id=8f644e481123734a0ca109ad61c1382eef30c5d486c22f3fae41013115a786fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746095435,
      "headline": "CVS posts Q1 earnings beat, raises full-year guidance",
      "id": 134173514,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare Advantage headwinds.",
      "url": "https://finnhub.io/api/news?id=8f644e481123734a0ca109ad61c1382eef30c5d486c22f3fae41013115a786fa"
    }
  },
  {
    "ts": null,
    "headline": "CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE",
    "summary": "CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2025.",
    "url": "https://finnhub.io/api/news?id=48cc8b841391e0f39d67d23698a9e5d6a93dca0b49465321e447ef004a590f9f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746095400,
      "headline": "CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE",
      "id": 134173743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2025.",
      "url": "https://finnhub.io/api/news?id=48cc8b841391e0f39d67d23698a9e5d6a93dca0b49465321e447ef004a590f9f"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Stocks get boost from Microsoft, Meta with jobs data on deck",
    "summary": "Stocks are set to kick-off the month of May on a high note, with megacap tech earnings driving solid premarket gains.",
    "url": "https://finnhub.io/api/news?id=7249c45b4ca7527d3e11d1dd195f11583043511ad67e0475bfb9511058402244",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746094048,
      "headline": "Stock Market Today: Stocks get boost from Microsoft, Meta with jobs data on deck",
      "id": 134173744,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Stocks are set to kick-off the month of May on a high note, with megacap tech earnings driving solid premarket gains.",
      "url": "https://finnhub.io/api/news?id=7249c45b4ca7527d3e11d1dd195f11583043511ad67e0475bfb9511058402244"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
    "summary": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
    "url": "https://finnhub.io/api/news?id=a6e5ebc06f9c3e91192386c3e82936ec6fa27d0eed4f6d5b5a6652b18fa25ad6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746094020,
      "headline": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
      "id": 134179448,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
      "url": "https://finnhub.io/api/news?id=a6e5ebc06f9c3e91192386c3e82936ec6fa27d0eed4f6d5b5a6652b18fa25ad6"
    }
  },
  {
    "ts": null,
    "headline": "CVS Stock Climbs After Wegovy Deal, Strong 1Q",
    "summary": "CVS Stock Climbs After Wegovy Deal, Strong 1Q",
    "url": "https://finnhub.io/api/news?id=b724b833c3b52a004e5725fb6128585d26b22255ff5c907f4b452a4478f18644",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746091200,
      "headline": "CVS Stock Climbs After Wegovy Deal, Strong 1Q",
      "id": 134192773,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Stock Climbs After Wegovy Deal, Strong 1Q",
      "url": "https://finnhub.io/api/news?id=b724b833c3b52a004e5725fb6128585d26b22255ff5c907f4b452a4478f18644"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health’s Aetna to exit Obamacare business, boost Wegovy access",
    "summary": "CVS Health’s Aetna to exit Obamacare business, boost Wegovy access",
    "url": "https://finnhub.io/api/news?id=2bbffbd3ba17446df89b09f1bc82cbd7312a1209bd2117ed796c36c2ca2c4341",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746087000,
      "headline": "CVS Health’s Aetna to exit Obamacare business, boost Wegovy access",
      "id": 134179449,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health’s Aetna to exit Obamacare business, boost Wegovy access",
      "url": "https://finnhub.io/api/news?id=2bbffbd3ba17446df89b09f1bc82cbd7312a1209bd2117ed796c36c2ca2c4341"
    }
  },
  {
    "ts": null,
    "headline": "CVS plans to exit ACA individual exchanges, strikes Wegovy deal with Novo Nordisk",
    "summary": "Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish drugmaker Novo Nordisk that should expand access to its in-demand GLP-1 at the expense of Eli Lilly’s.",
    "url": "https://finnhub.io/api/news?id=97439800974d15ca03782fd9e14d590e703248756a3813ee733f836b596f1b8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746084288,
      "headline": "CVS plans to exit ACA individual exchanges, strikes Wegovy deal with Novo Nordisk",
      "id": 134173745,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish drugmaker Novo Nordisk that should expand access to its in-demand GLP-1 at the expense of Eli Lilly’s.",
      "url": "https://finnhub.io/api/news?id=97439800974d15ca03782fd9e14d590e703248756a3813ee733f836b596f1b8a"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health : First Quarter 2025 Q1 2025 Non-GAAP Reconciliation",
    "summary": "‌Q1 2025 ACTUAL RESULTS CVS Health Corporation uses non-GAAP financial measures to analyze underlying business performance and trends. The Company believes that providing...",
    "url": "https://finnhub.io/api/news?id=78081b9975b7946ca28aaa1eb73ecc81c3fbc63fc19caf99583febfc440e4263",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746082988,
      "headline": "CVS Health : First Quarter 2025 Q1 2025 Non-GAAP Reconciliation",
      "id": 134170624,
      "image": "",
      "related": "CVS",
      "source": "Finnhub",
      "summary": "‌Q1 2025 ACTUAL RESULTS CVS Health Corporation uses non-GAAP financial measures to analyze underlying business performance and trends. The Company believes that providing...",
      "url": "https://finnhub.io/api/news?id=78081b9975b7946ca28aaa1eb73ecc81c3fbc63fc19caf99583febfc440e4263"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health raises annual profit forecast as turnaround gathers steam",
    "summary": "CVS Health raised itsfull-year profit forecast on Thursday following strongperformance across its businesses, signaling an early recoveryafter a series of troubles hit the healthcare conglomerate...",
    "url": "https://finnhub.io/api/news?id=96cb91d20e1dea126c012abe78d4cbebda537c0828f8122bce816e5653fa2e51",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746081387,
      "headline": "CVS Health raises annual profit forecast as turnaround gathers steam",
      "id": 134170316,
      "image": "",
      "related": "CVS",
      "source": "Finnhub",
      "summary": "CVS Health raised itsfull-year profit forecast on Thursday following strongperformance across its businesses, signaling an early recoveryafter a series of troubles hit the healthcare conglomerate...",
      "url": "https://finnhub.io/api/news?id=96cb91d20e1dea126c012abe78d4cbebda537c0828f8122bce816e5653fa2e51"
    }
  },
  {
    "ts": null,
    "headline": "Apple and Amazon.com headline earnings",
    "summary": "Apple and Amazon.com headline earnings",
    "url": "https://finnhub.io/api/news?id=aea36bfd24e1ade1e34f0b905e1e464d4c9742dc5ed129a787a8b2a2b35c2ef2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746077102,
      "headline": "Apple and Amazon.com headline earnings",
      "id": 134179451,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "Apple and Amazon.com headline earnings",
      "url": "https://finnhub.io/api/news?id=aea36bfd24e1ade1e34f0b905e1e464d4c9742dc5ed129a787a8b2a2b35c2ef2"
    }
  }
]